Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. - Smith,M.R.; Fallon,M.A.; Lee,H.; Finkelstein,J.S. (J Clin Endocrinol Metab, 2004)